Immunogenic formulation of ospc antigen vaccines for the...

Details Immunogenic formulation of ospc antigen vaccines for the... Immunogenic formulation of ospc antigen vaccines for the...

C - Chemistry, Metallurgy

12

N

C12N 15/31 (2006.01) A61K 39/02 (2006.01) A61K 39/39 (2006.01) C07K 14/195 (2006.01) C07K 14/20 (2006.01) C12N 1/19 (2006.01) C12N 1/21 (2006.01) C12N 15/70 (2006.01) C12N 15/81 (2006.01) A61K 39/00 (2006.01)

Patent

CA 2161534

AD approach to Borrelia vaccine formulation taking into account serological, genotypic and epidemiological information by which OspC proteins from different strains of B. burgdorferi are grouped together. OspC antigens are chosen in order to constitute a representative sample of such groupings so that the resulting vaccine provides the greatest cross-protectivity with the fewest number of antigens.

Affiliated with

Also associated with

Rating

Immunogenic formulation of ospc antigen vaccines for the... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Immunogenic formulation of ospc antigen vaccines for the..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Immunogenic formulation of ospc antigen vaccines for the... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1497064